Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  Flowr Corp    FLWR   CA34354X1087

FLOWR CORP

(FLWR)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tsx Venture Exchange
06/19/2019 06/20/2019 06/21/2019 06/24/2019 06/25/2019 Date
7.26(c) 7.23(c) 7.26(c) 7.1(c) 5.69(c) Last
128 114 93 180 109 390 76 611 604 591 Volume
+0.41% -0.41% +0.41% -2.20% -19.86% Change
More quotes
Financials (CAD)
Sales 2019 24,9 M
EBIT 2019 -19,1 M
Net income 2019 -13,5 M
Debt 2019 -
Yield 2019 -
Sales 2020 141 M
EBIT 2020 2,70 M
Net income 2020 1,80 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 236,67
Capi. / Sales2019 25,5x
Capi. / Sales2020 4,48x
Capitalization 633 M
More Financials
Company
Flowr Corp, formerly known as Needle Capital Corp, is a Canada-based vertically-integrated cannabis company. The Company builds and operates Good Manufacturing Practice (GMP) compliant cultivation facilities utilizing their own growing systems. Its investment in research and development enables its... 
Sector
Pharmaceuticals
Calendar
06/25Presentation
More about the company
Latest news on FLOWR CORP
06/25The Flowr Corporation Announces Public Offering of Common Shares for Approxim..
GL
06/24Flowr to Acquire 100% Interest in Holigen
GL
06/17FLOWR : Announces Commitment for $50 Million Senior Secured Credit Facility
AQ
05/31FLOWR : to Participate on Cannabis Panel at the Piper Jaffray Consumer Marketpla..
AQ
05/23FLOWR : Receives NASDAQ Listing Approval
AQ
05/17FLOWR : Announces Results for the First Quarter 2019
AQ
05/11FLOWR : Completes Private Placement for Approximately C$13.5 Million
AQ
05/10FLOWR : Completes Private Placement for Approximately C$13.5 Million
AQ
04/29Flowr Provides Corporate Update
GL
04/04The Flowr Corporation Announces Results for the Fourth Quarter and Full Year ..
GL
More news
Sector news : Alternative Medicine
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25Nestlé, Novartis Among Companies at Risk of London Trading Ban -- 2nd Update
DJ
06/25AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan
RE
06/25ABBVIE : S&P Puts AbbVie on Watch Negative After Allergan Deal
DJ
06/25Nestlé, Novartis at Risk of London Trading Ban -- Update
DJ
More sector news : Alternative Medicine
Chart FLOWR CORP
Duration : Period :
Flowr Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 7,65  CAD
Spread / Average Target 7,7%
Managers
NameTitle
Tom Flow Co-Chief Executive Officer & Director
Vinay Tolia Co-Chief Executive Officer & Director
Lance Emanuel President
Steven A. Klein Chairman & Chief Strategy Officer
Alexander Dann Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
FLOWR CORP61.73%451
CANOPY GROWTH CORP46.22%13 302
AURORA CANNABIS INC46.61%7 269
BEIJING TONGRENTANG CO., LTD.4.95%5 826
CRONOS GROUP INC48.40%4 534
DONG-E-E-JIAO CO LTD--.--%3 842